FLDPF yields 357142.86% · PFE yields 6.13%● Live data
📍 FLDPF pulled ahead of the other in Year 1
Combined, FLDPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FLDPF + PFE for your $10,000?
Frontline Gold Corporation, a junior mineral exploration company, acquires, explores for, and evaluates natural resource properties in Canada and Turkey. Its primary assets include Cameron Lake/Flint Lake property that comprises 21 mining claims located in the Rainy River area, Ontario; the Copperlode property consisting of 25 claim cells and 7 boundary cells covering an area of approximately 540 hectares; the Crooked Pine Lake project comprising of 8 multi-cell claims totaling 5,703 hectares situated in Ontario; and the Menderes gold project, which include 4 permits consisting of 6,194 hectares located in Turkey. The company also holds interest in the Red Lake mining division that comprises seven claim groups totaling 262 individual claims covering 4,900 hectares located in Red Lake, Ontario; the Whitehorse Island property that consists of two claims covering a total area of 35.55 hectares; the Portage River project consisting of 28 claims covering an area of 1,567 hectares located to the north of La Sarre, Quebec; the Route 109 project that comprises of 100 mining claims covering an area of approximately 5,588 hectares located in Matagami, Quebec; the Granite Ridge property that includes 49 claims covering an area of 995 hectares located in Ontario; and the Paint Lake Road property, which consists of 6 claims covering 3,610 hectares located in Ontario. In addition, it holds interest in the Epworth project consisting of 5 claims covering an area of 1,300 hectares situated in Nunavut; and the NE Bachelor property that consists of 62 mining claims covering 3,454 hectares located in Waswanipi, Quebec. The company was formerly known as Chrysos Capital Corporation and changed its name to Frontline Gold Corporation in March 2010. Frontline Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.
Full FLDPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.